| Michael Ah You, DNP, PMHNP-BC | |
|
672 W 400 S Ste 201, Springville, UT 84663-3170 | |
| (801) 369-8989 | |
| (801) 704-9741 |
| Full Name | Michael Ah You |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 672 W 400 S Ste 201, Springville, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396412698 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 7868046-4405 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cedar Psychiatry Llc | 2163750688 | 37 |
News Archive
Scientists have issued a warning to women about using talcum powder - they say it increases their risk of developing ovarian cancer.
As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.
News outlets report on a variety of health policy issues in Texas, Minnesota, Georgia, Kansas, Massachusetts, Ohio, Florida and Pennsylvania.
Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.
› Verified 5 days ago
| Entity Name | Sundance Behavioral Resources Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326157355 PECOS PAC ID: 5496979239 Enrollment ID: O20140617001287 |
News Archive
Scientists have issued a warning to women about using talcum powder - they say it increases their risk of developing ovarian cancer.
As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.
News outlets report on a variety of health policy issues in Texas, Minnesota, Georgia, Kansas, Massachusetts, Ohio, Florida and Pennsylvania.
Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.
› Verified 5 days ago
| Entity Name | Cedar Psychiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265092282 PECOS PAC ID: 2163750688 Enrollment ID: O20190822000230 |
News Archive
Scientists have issued a warning to women about using talcum powder - they say it increases their risk of developing ovarian cancer.
As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.
News outlets report on a variety of health policy issues in Texas, Minnesota, Georgia, Kansas, Massachusetts, Ohio, Florida and Pennsylvania.
Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Ah You, DNP, PMHNP-BC 672 W 400 S Ste 201, Springville, UT 84663-3170 Ph: (801) 369-8989 | Michael Ah You, DNP, PMHNP-BC 672 W 400 S Ste 201, Springville, UT 84663-3170 Ph: (801) 369-8989 |
News Archive
Scientists have issued a warning to women about using talcum powder - they say it increases their risk of developing ovarian cancer.
As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.
News outlets report on a variety of health policy issues in Texas, Minnesota, Georgia, Kansas, Massachusetts, Ohio, Florida and Pennsylvania.
Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.
› Verified 5 days ago
Erin Anna Tyrrell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5 E 400 N, Springville, UT 84663 Phone: 801-489-8464 Fax: 801-798-8513 | |
Mrs. Lindsey Gray Mortensen, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1806 E 250 S, Springville, UT 84663 Phone: 801-367-1490 | |
Ellen Brown, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 677 S 950 W, Springville, UT 84663 Phone: 435-621-9335 | |
Desaree Fowler, PNP-PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 672 W 400 S Ste 101, Springville, UT 84663 Phone: 801-491-9883 Fax: 801-489-3141 | |
Michelle Brandt, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5 E 400 N, Springville, UT 84663 Phone: 801-489-8464 | |
Danielle Alair Bate, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5 E 400 N, Springville, UT 84663 Phone: 801-489-8464 | |
Amelia Pinegar, RN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 762 W 400 S, Springville, UT 84663 Phone: 801-429-1210 |